Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Nature Communications
|
November 19, 2021
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
Alison E Smith, Emanuela Ferraro, Anton Safonov, et al.
Nature Communications
|
April 6, 2016
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
Felipe Slebe, Federico Rojo, Maria Vinaixa, et al.
Science Advances
|
May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
Anna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell, et al.
Cancer Discovery
|
September 13, 2023
Early-Stage Breast Cancer Detection in Breast Milk
Cristina Saura, Carolina Ortiz, Judit Matito, et al.
Genome Medicine
|
August 26, 2024
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models
Andrea Herencia-Ropero, Alba Llop-Guevara, Anna D Staniszewska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2022
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
Queralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros, et al.
Science Translational Medicine
|
October 5, 2018
p95HER2-T cell bispecific antibody for breast cancer treatment
Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho, et al.
Nature Cell Biology
|
April 21, 2018
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancer
Sylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Nature Cell Biology
|
January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancer
Sylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Cancer Research
|
April 15, 2022
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Nature Communications
|
November 19, 2021
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
Alison E Smith, Emanuela Ferraro, Anton Safonov, et al.
Nature Communications
|
April 6, 2016
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
Felipe Slebe, Federico Rojo, Maria Vinaixa, et al.
Science Advances
|
May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
Anna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell, et al.
Cancer Discovery
|
September 13, 2023
Early-Stage Breast Cancer Detection in Breast Milk
Cristina Saura, Carolina Ortiz, Judit Matito, et al.
Genome Medicine
|
August 26, 2024
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models
Andrea Herencia-Ropero, Alba Llop-Guevara, Anna D Staniszewska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2022
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
Queralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros, et al.
Science Translational Medicine
|
October 5, 2018
p95HER2-T cell bispecific antibody for breast cancer treatment
Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho, et al.
Nature Cell Biology
|
April 21, 2018
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancer
Sylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Nature Cell Biology
|
January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancer
Sylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Cancer Research
|
April 15, 2022
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, et al.
Page
of 2